All In Biotech

Drug Trial Radar · NCT07448610

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

Onasemnogene Abeparvovec: ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Aug 27, 2026

Primary completion

May 3, 2032

Study completion Jun 30, 2032

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose is to address critical evidence in the treatment landscape for Spinal Muscular Atrophy (SMA), specifically focusing on the intrathecal formulation of onasemnogene abeparvovec-brve (ITVISMA®). U.S. Pragmatic Multicenter Study (STREAM).

Conditions

  • Spinal Muscular Atrophy

Interventions

  • Onasemnogene Abeparvovec-brveDrug

    administered once via lumbar puncture with systemic corticosteroid prophylaxis per label.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in HFMSE for independently ambulatory participantsTime frame: Baseline, 6, 12, 18 and 24 months
  2. Change from baseline in RULM for non-ambulatory (including walkers with assistance) participantsTime frame: Baseline, 6, 12, 18 and 24 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Stanford Hospital

    Stanford, California · Recruiting

  • Boston Childrens Hospital

    Boston, Massachusetts · Recruiting

  • Columbia University Medical Center

    New York, New York · Recruiting

  • Ohio State University Medical Center

    Columbus, Ohio · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.